Stockwinners Market Radar for October 10, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

23:12 EDT Tesla CEO introduces high-density 'robo-van' with 20-person capacity

23:03 EDT Tesla CEO says we'll move to 'unsupervised full self driving' - Says the cost will be below $30K. Says you'll be able to fall asleep and arrive at your destination. Says autonomous cars can be used up to 8 times more than currently. Says autonomous cars can become 10-times safer than human-driven. Says in autonomous world, the car is like a "little lounge".

20:12 EDT Cathie Wood's ARK Investment buys 26K shares of Blade Air Mobility today

19:50 EDT Alternus Clean Energy Inc trading halted, news pending

18:49 EDT Xbox president says Google mobile ruling to allow 'more choice' - Xbox (MSFT) president Sarah Bond said in a post on X, formerly Twitter, "The court's ruling to open up Google's (GOOG) mobile store in the US will allow more choice and flexibility. Our mission is to allow more players to play on more devices so we are thrilled to share that starting in November, players will be able to play and purchase Xbox games directly from the Xbox App on Android." Reference Link

18:27 EDT Embraer's E-Freighter certified by the FAA - The E-Freighter, Embraer's E190F has been fully certified by the Federal Aviation Administration. Embraer's passenger-to-freighter conversion and the Cargo Loading System, developed by U.S. Cargo Systems, have received the certification by FAA in September 2024. In July, the E-Freighter was certified by the National Civil Aviation Agency of Brazil and EASA certification is due later this year. The aircraft was developed to fill a gap in the air cargo market and to replace older, less efficient models. The E190F program was launched in May 2022 to meet the changing demands of e-commerce and modern trade, which require fast deliveries and decentralized operations driving the demand for faster delivery of shipments to regional markets. The E-Freighter made its debut flight in April and its first public appearance during the Farnborough Airshow in July. "FAA certification is an important milestone in our passenger-to-freighter conversion program. We are excited to enter this market, filling a gap that has evolved in the market to meet the growing demand globally for faster deliveries, not just to metro areas, but to all regions. With our E-Jet footprint across the US and worldwide, we are offering optimum cargo solutions to our customers for this connected world", said Martyn Holmes, Chief Commercial Officer, Embraer Commercial Aviation.

17:56 EDT Stellantis names Doug Ostermann as new CFO, Antonio Filosa as NA COO - The company states: "To drive simplification and enhance organisational performance in a turbulent global environment, Stellantis today announced targeted management changes, effective immediately, under the leadership of CEO Carlos Tavares to redouble the Company's focus on its key business priorities and confront head-on the global challenges facing the industry. Antonio Filosa is appointed North America Chief Operating Officer in addition to his role as Jeep(R) brand CEO succeeding Carlos Zarlenga whose next position will be subject to a further announcement. Having successfully led the excellent performance of Stellantis' South America Region, driving increased revenue, quality and market share, Antonio brings a wealth of business and leadership experience to this new role. Jean-Philippe Imparato is appointed Chief Operating Officer Enlarged Europe in addition to his role as CEO of Pro One succeeding Uwe Hochgeschurtz who will leave the Company. With almost 34 years experience in brands, business units and commercial network management with the Company, Jean-Philippe will reinforce the commercial performance of the region during the critical period of the energy transition, with his particular focus on sales. Doug Ostermann is appointed Chief Financial Officer succeeding Natalie Knight who will leave the Company. Doug has more than 19 years experience in finance across three international groups including Stellantis and another OEM and was previously Stellantis China's Chief Operating Officer. Doug has wide-ranging experience in the automotive industry as well as in P&L management and finance. Gregoire Olivier is appointed as Chief Operating Officer China and remains the Liaison Officer to Leapmotor, leveraging his expert knowledge and experience of the Chinese market. Santo Ficili is appointed CEO of Maserati and Alfa Romeo and member of the Top Executive Team, taking advantage of his extensive knowledge of the automotive sector and commercial operations. Davide Grasso's next position will be subject to a further announcement."

17:33 EDT Procaps Group CEO issues letter to shareholders amid independent investigation - Procaps Group issued a letter to shareholders from CEO Jose Antonio Vieira, providing updates on the company's independent investigation, financial restatement and governance enhancements. "...Our approach centers on four key areas of improvement: 1. Completing the Independent Investigation. The independent investigation led by our Audit Committee, supported by external advisors, to address historical accounting matters remains ongoing. As disclosed in our recent 6-K filing, the preliminary findings underscore challenges from past practices; however, we have made considerable progress toward resolution and are focused on implementing the necessary steps to strengthen Procaps for the future. As part of this process, we have confirmed the need for applicable historical financial statements to be restated. While we aim to progress the restatement process and finalize the 2023 20-F as promptly as possible, we recognize that, given the complexity of this effort, our timeline to do so will extend significantly beyond our original expectations. We are focused on ensuring our disclosures are complete, accurate, and aligned with required standards. 2. Addressing Financial Discrepancies and Financial Restatement. The independent investigation has identified certain historical transactions that were improperly accounted for and other accounting errors, as described in our most recent 6-K filing. These transactions, although they originated prior to our listing on Nasdaq, have had a continuing impact our financial statements. We are working diligently to address these matters, including through the restatement of our financials and enhancements to our internal controls. Our commitment to integrity and transparency is unwavering, and we will continue to take all necessary steps to rectify these issues. 3. Governance and Compliance Enhancements. To strengthen oversight and in response to the findings of the ongoing independent investigation, we are implementing a comprehensive remediation plan designed to strengthen governance and compliance across all levels. Key elements of this plan include: Board and Management Oversight: To strengthen governance at the highest levels, we are implementing a multi-year plan to transition to an independent board that includes independent search for directors - led by the Nomination and Governance Committee - with expertise in SOX compliance, corporate governance, and industry knowledge and any other key capabilities essential to Procaps' strategic goals. Following the recent resignation of a Board member, the Board is actively working to identify a qualified successor who will support our commitment to enhanced governance and alignment with long-term objectives. Strengthening Internal Controls: As part of our remediation Plan, we are redesigning our finance and supporting functions, such as centralizing oversight of all finance areas, launching training programs focused on internal controls and SOX compliance, and enhancing the oversight role of our Audit Committee. These measures are intended to prevent future issues and restore the trust of our stakeholders. Enhanced Financial Controls and Compliance: We are reinforcing financial reporting processes and SOX compliance by implementing automated controls, improved monitoring systems, and regular SOX compliance training for all relevant teams. These improvements are already underway and will be further strengthened as necessary in response to the findings of the investigation. Thorough Personnel and Contract Review: We are conducting a comprehensive review of all other personnel potentially involved in the transactions being investigated and assessing existing related party contracts for alignment with our governance standards. Culture of Ethics and Transparency: We are launching targeted training programs to promote ethics and compliance across all organizational levels, reinforcing a culture of integrity and accountability. These initiatives are designed to reinforce ethical governance across every level of the organization, with a commitment to ensuring that Procaps operates in accordance with the highest industry standards. 4. Restructuring Plan and Financial Stability. We recognize the critical importance of a stable financial foundation. In conjunction with our remediation plan, we are also pursuing a long-term restructuring plan that involves exploring new funding sources and other strategies to support the long-term sustainability of our operations. This includes proactive engagement with our lenders, shareholders, and strategic partners to secure new capital and resources aligned with our strategic goals..."

17:08 EDT Aura Minerals reports preliminary Q3 production 68,246 gold equivalent ounces - Aura Minerals announces Q3 2024 preliminary production results from the company's four operating mines: Aranzazu, Apoena, Minosa and Almas. Total production in Q3 reached 68,246 gold equivalent ounces, 10% above the second quarter of 2024 and 10% above the same period last year at constant metal prices. The highlights of the quarter were the performance of Almas, where production stabilized at 15k GEO after a contractor replacement in Q2 2024, reaching what the company considers a consistent level for the operation, and Minosa, which recorded another quarterly production growth. This quarter, Aura achieved a new record high LTM production, with 269,953 GEO produced in the period.

17:02 EDT AptarGroup authorizes share repurchase of up to $500M, declares 45c dividend - AptarGroup authorized the repurchase of up to $500M of the company's common stock. This new authorization replaces all previous authorizations. The Board also declared a quarterly cash dividend of 45c per share. The payment date is November 14, to stockholders of record as of October 24.

17:00 EDT MSC Industrial raises quarterly dividend to 85c per share from 83c - The dividend is payable on November 27, 2024 to shareholders of record at the close of business on November 13, 2024.

16:35 EDT Robinhood director sells $80.9M in common stock - In a regulatory filing, Robinhood disclosed that its director Meyer Malka sold 3.23M shares of common stock on October 8th in a total transaction size of $80.9M.

16:31 EDT Lincoln Electric names Steven Hedlund as new Board Chair - Lincoln Electric "announced that Christopher L. Mapes, Executive Chair, will retire from his position as Executive Chair and a member of the Board of Directors on December 31, 2024. The Board of Directors has elected Steven B. Hedlund, currently CEO and a Director, to succeed Mr. Mapes as Chair of the Board, effective January 1, 2025. Mr. Hedlund will assume this position in addition to his role as President and CEO."

16:26 EDT Sandstorm Gold sees Q3 revenue $44.7M, consensus $45.5M - Reports Q3 gold sales of 17,350 attributable gold equivalent ounces. Preliminary cost of sales, excluding depletion for the three months ended September 30, was $5.3M resulting in cash operating margins of approximately $2,215 per attributable gold equivalent ounce - $4.7M and $1,699 per attributable gold equivalent ounce for the comparable period in 2023, respectively.

16:20 EDT Carpenter Technology appoints Ball Corp. CFO Howard Yu to board - Carpenter Technology (CRS) announced that Howard Yu has been appointed to the company's board of directors, effective October 9. Yu brings more than 25 years of financial leadership experience in large multinational organizations. Yu is currently the executive VP, CFO for Ball Corp. (BALL).

16:17 EDT Piedmont Office Realty reports virtually no damage from Hurricane Milton - Piedmont Office Realty announced that its property management team, after reviewing detailed property reports for all of the company's Orlando assets, has reported virtually no damage to any of Piedmont's properties from Hurricane Milton and that all personnel in the affected areas are reported safe.

16:14 EDT Qiagen expands automated liquid biopsy portfolio - Qiagen announced key updates to its sample technologies solutions for non-invasive liquid biopsy applications for use in research and clinical applications such as oncology, prenatal care and organ transplantation.

16:12 EDT FDA Approves Genentech's Itovebi in HER2-negative breast cancer - The company states: "Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration approved Itovebi, in combination with palbociclib, Ibrance, and fulvestrant, for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy. The PIK3CA mutation is found in approximately 40% of HR-positive metastatic breast cancers. This approval is based on results of the pivotal Phase III INAVO120 study, which showed that the Itovebi-based regimen reduced the risk of disease worsening or death by 57% compared with palbociclib and fulvestrant alone in the first-line setting, demonstrating a statistically significant and clinically meaningful benefit. Overall survival (OS) data were immature at the time of primary analysis, but a clear positive trend was observed (stratified HR=0.64, 95% CI: 0.43-0.97, p=0.0338 [boundary of 0.0098]). Follow-up for OS is continuing to the next analysis. The Itovebi-based regimen was granted FDA Priority Review and Breakthrough Therapy Designation in May 2024 based on the INAVO120 study results. Data from INAVO120 are also being used for filing submissions to other global health authorities, including the European Medicines Agency. Itovebi will be available in the U.S. in the coming weeks. Early, comprehensive biomarker testing with an FDA-approved test, such as Foundation Medicine's FoundationOne(R)Liquid CDx, can help identify people with HR-positive, HER2-negative breast cancer with a PIK3CA mutation."

16:11 EDT Senseonics says first commercial patient received Eversense 365 CGM system - Senseonics Holdings announced that the first commercial patient received the next-generation Eversense 365 CGM system. This milestone, part of the company's previously announced collaboration with Mercy, marks the world's first commercial use of Eversense 365, the only CGM to provide one-year of accurate monitoring with minimal interruptions.

16:04 EDT Allakos announces results from AK006 study - Allakos announced results from the Phase 1 study of subcutaneous AK006 in healthy volunteers. AK006 is a Siglec-6 monoclonal antibody that selectively inhibits mast cells. Inappropriate activation of mast cells has been identified as a pathogenic driver of multiple diseases, including chronic spontaneous urticaria, food allergy and asthma. Bioavailability of subcutaneous AK006 was approximately 77%. Subcutaneous administered AK006 showed an estimated half-life of 12-22 days. Consistent with the IV formulation, skin biopsies taken from subcutaneous AK006 treated healthy volunteers showed high levels of receptor occupancy confirming AK006 reaches skin tissue mast cells. The 720 mg dose of AK006 showed 98% receptor occupancy at day 113 suggesting the potential for infrequent dosing. Single and multiple doses of IV AK006 and single dose subcutaneous AK006 up to 720 mg were well-tolerated with a favorable safety profile. In the safety profile to date: There were no serious adverse events, or SAEs, in subjects on AK006. There were no treatment emergent adverse events leading to discontinuation of AK006. There were no dose limiting toxicities. The most common adverse events occurring more frequently in subjects on AK006 were headache and dysmenorrhea, all of which were mild-to-moderate in severity.

16:02 EDT Tredegar launches Obsidian Automotive Protective Films - Tredegar Surface Protection, a subsidiary of Tredegar Corporation, announced the launch of Obsidian Automotive Protective Films. Designed to meet the evolving needs of the automotive industry, these innovative films offer unparalleled performance and protection, the company said. "At Tredegar Surface Protection, we are committed to pushing the boundaries of innovation in masking products. Using our technological expertise and research and development capabilities, we have created our line of Obsidian Automotive Protective Films to provide a range of solutions for the automotive industry. In particular, the demand for surface protection of automotive displays is growing significantly, with an increase in both the size of displays and the areas for displays in each automobile," said Arijit (Bapi) DasGupta, President, PE Films / Tredegar Surface Protection. "As the industry leader in surface protection films, we are uniquely qualified to support our customers' needs."

15:49 EDT FDA approves Roche's inavolisib combo for metastatic breast cancer - The Food and Drug Administration approved inavolisib, or Itovebi, from Genentech, with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, human epidermal growth-factor receptor 2-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy. FDA also approved the FoundationOne Liquid CDx assay as a companion diagnostic device to identify patients with breast cancer for treatment with inavolisib with palbociclib and fulvestrant. Reference Link

15:31 EDT Triumph Group trading resumes

14:36 EDT Blue Owl, Upstart partner over consumer credit in $2B pact - Upstart (UPST) announced a programmatic purchase commitment from funds managed by Blue Owl Capital (OWL). Blue Owl's Alternative Credit strategy will purchase up to $2B of consumer loans on the Upstart platform over 18 months. The transaction includes an initial acquisition of a $290M personal loan portfolio, which closed in September. "We are excited to support Upstart's efforts to make the consumer lending process dramatically more efficient for both borrowers and lenders," said David Aidi, Co-Head of Financial Assets, Blue Owl Alternative Credit. "We are also proud to leverage the Blue Owl Alternative Credit team's data science effort and deep experience in the consumer space to join Upstart in this journey," said Ray Chan, Co-Head of Financial Assets, Blue Owl Alternative Credit. "We're thrilled to partner with the Blue Owl team in one of our largest purchase commitments ever," said Sanjay Datta, CFO, Upstart. "Blue Owl's ambitious vision and long-term focus will accelerate our efforts to expand access to affordable credit." The transaction was structured and closed by Atalaya Capital Management LP, an alternative credit manager that focused primarily on asset-based credit investments across consumer and commercial finance, corporate, and real estate assets. Blue Owl completed its acquisition of Atalaya on Sept. 30, representing a significant expansion of Blue Owl's alternative credit presence and supplementing its market-leading position in direct lending.

14:29 EDT Regencell Bioscience Holdings Ltd trading halted, volatility trading pause

14:29 EDT RIV Capital, Cansortium announce NY Cannabis Control Board approval of merger - RIV Capital (CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform, and Cansortium (CNTMF), a vertically integrated, multi-state cannabis company operating under the FLUENT brand, announced that they have received New York Cannabis Control Board approval for their previously announced business combination. The business combination is expected to close in the fourth quarter of 2024, subject to, the satisfaction of the other closing conditions set forth in the arrangement agreement. "With this integration process already well underway, we are strongly positioned to become more competitive and better equipped with the resources needed to develop even better cannabis products to serve New York consumers rapidly expanding demand. Since launching adult-use sales in New York earlier this year we've seen tremendous momentum at all three of our co-located locations and the rapid expansion of our statewide wholesale business. Beyond adult use, we will lean on the medical program expertise of Fluent to further support our current medical locations and look to potential expand the reach to more New Yorkers," said Dave Vautrin, Chief Retail Officer and Interim Chief Executive Officer of RIV Capital.

14:19 EDT Galaxy Payroll Group Ltd trading halted, volatility trading pause

14:09 EDT Supermicro introduces new servers, GPU accelerated systems - Supermicro (SMCI) announced the launch of a new series of servers, GPU-accelerated systems, and storage servers featuring the AMD (AMD) EPYC 9005 Series processors and AMD Instinct MI325X GPUs. The new H14 product line represents one of the most extensive server families in the industry, including Supermicro's Hyper systems, the Twin multi-node servers, and AI inferencing GPU systems, all available with air or liquid cooling options, the company said. "The new "Zen5" processor core architecture implements full data path AVX-512 vector instructions for CPU-based AI inference and provides 17% better instructions per cycle than the previous 4th generation EPYC processor, enabling more performance per core." Supermicro's new H14 family uses the latest 5th Gen AMD EPYC processors which enable up to 192 cores per CPU with up to 500W TDP, or thermal design power. Supermicro has designed new H14 systems, including the Hyper and FlexTwin systems which can accommodate the higher thermal requirements. The H14 family also includes three systems for AI training and inference workloads supporting up to 10 GPUs which feature the AMD EPYC 9005 Series CPU as the host processor and two which support the AMD Instinct MI325X GPU. Supermicro will present the new H14 solutions at the AMD Advancing AI Day on October 10, 2024, at the San Francisco Moscone Center.

13:59 EDT United Parks & Resorts says SeaWorld Orlando to reopen on Friday - United Parks & Resorts said that following Hurricane Milton, its team is evaluating the parks. All date-intended tickets for closure days have been extended through December 31, 2024 and require no action to be taken. Howl-O-Scream tickets may be used for any remaining Howl-O-Scream event nights. The company says Busch Gardens Tampa and Adventure Island are currently closed; SeaWorld Orlando will be open on Friday, October 11th, but Spooktacular and Howl-O-Scream events are cancelled for Friday; and Aquatica Orlando and Discovery Cove will be open on Friday as well.

13:41 EDT Treasury announces $1.3B penalty on TD Bank - Deputy Secretary of the Treasury Wally Adeyemo stated at a press conference at the Department of Justice, according to prepared remarks: "The Department of the Treasury utilizes sanctions and the enforcement of our country's anti-money laundering - AML- laws to protect our national security from illicit actors. From drug trafficking to combatting Russian aggression, the Treasury Department is committed to using all of the tools available to us to protect the American people. We are proud of the public-private partnership we have formed with the financial sector to protect our national security. The vast majority of financial institutions work hand-in-hand with Treasury to keep our country and our communities safe. TD Bank has done the exact opposite. For more than a decade, through deliberate actions-and inaction-TD Bank failed to meet its responsibilities. TD Bank failed to implement or maintain a sufficient AML compliance program. TD Bank failed to monitor trillions of dollars in transactions each year, including those the Bank knew posed a high-risk for abuse. TD Bank failed to conduct adequate due diligence on high-risk customers, ignoring glaring red flags. TD Bank failed to live up to its responsibilities to the American people. I want to be clear, these systemic failures did not just create hypothetical vulnerabilities, but they resulted in actual, material harm to American citizens and communities. Time and again, unlike its peers, TD Bank prioritized growth and profit over complying with the law... That's why today we are announcing the Financial Crimes Enforcement Network's - FinCEN - $1.3 billion penalty on TD Bank, the largest civil monetary penalty against a bank in Treasury's history. In addition to a historic penalty, TD Bank has agreed to a four-year monitor to oversee its extensive remedial measures, including end-to-end review of its AML program. The bank will also be required to provide missing suspicious activity reports and, for the first time, FinCEN will require additional accountability and data governance reviews to provide recommendations for changing TD Bank's culture of noncompliance. Together, these requirements hold TD Bank accountable for its egregious and willful disregard of the law and the real harm it caused. This action demonstrates that we are committed to holding individuals and institutions accountable." Reference Link

13:15 EDT Office of the Comptroller says may require TD Bank to reduce assets by 7% - The Office of the Comptroller of the Currency said that if TD Bank "does not achieve compliance with all actionable articles in the order by the timeline approved by the OCC, the OCC may, in its discretion, require the bank to reduce its total consolidated assets by up to 7%." Reference Link

13:12 EDT Office of the Comptroller fines TD Bank $450, issues cease and desist order - The Office of the Comptroller of the Currency announced a cease and desist order and a $450M civil money penalty against TD Bank for deficiencies in the bank's Bank Secrecy Act and anti-money laundering compliance program. Today's action also imposes a restriction on the growth of the bank and a measure designed to ensure that the bank invests sufficient resources to remediate its deficiencies "in a timely manner," the agency said in a statement. Reference Link

12:05 EDT DoorDash spike attributed the Tesla partnership speculation - Shares of DoorDash (DASH) moved higher after an X account claimed to leak a video from Tesla's (TSLA) Robotaxi event tonight that highlights a partnership between Tesla's autonomous vehicles and DoorDash. Shares of DoorDash moved higher following the X post but have since moved lower. The stock in midday trading is up 81c to $143.46. Reference Link

12:00 EDT Atlas Energy falls -7.9% - Atlas Energy is down -7.9%, or -$1.71 to $19.95.

12:00 EDT Universal Insurance rises 10.0% - Universal Insurance is up 10.0%, or $1.69 to $18.65.

12:00 EDT GXO Logistics rises 14.5% - GXO Logistics is up 14.5%, or $7.37 to $58.27.

10:33 EDT D.E. Shaw says Air Products needs 'more rigorous capital allocation policy' - The D. E. Shaw group announced it sent an open letter to the board of directors of Air Products and Chemicals, calling for changes "aimed at addressing the longstanding underperformance in its shares and deficiencies in its governance and capital allocation policies." Funds advised by D. E. Shaw & Co., L.P. are shareholders of APD and currently hold "a significant economic position in the company," the firm stated. In the open letter, the firm stated in part: "We initially reached out to you privately over a month ago in the hopes of having a constructive dialogue aimed at addressing the Company's longstanding total shareholder return underperformance as well as deficiencies in the Company's governance and capital allocation policies... Despite having received our materials days in advance of the meeting, many of the Board members present seemed unwilling or unable to engage with the substance of our analysis and suggested actions. Instead, the Company's Lead Independent Director, Ed Monser, indicated that a substantive response would occur at a subsequent meeting. That follow-up meeting was abruptly cancelled by the Company's Lead Independent Director. Given the apparent lack of urgency on the part of the Company's Board to engage in meaningful dialogue or take steps to address Air Products' persistent and long-term share price underperformance, we are today compelled to make public our analysis and recommendations for change. We remain open to engaging with the Company in a productive and constructive manner to advance the changes we believe are necessary to improve the Company's business, strategy, and governance."

10:24 EDT Delta to introduce updated LT financial framework at next month's investor day

10:07 EDT Delta Air Lines CEO: Consumers prioritizing premium experiences

10:05 EDT Delta CEO says Delta One lounge in JFK has been 'incredible success'

10:00 EDT Sibanye Stillwater falls -8.6% - Sibanye Stillwater is down -8.6%, or -37c to $3.96.

10:00 EDT E2open falls -17.2% - E2open is down -17.2%, or -70c to $3.38.

10:00 EDT LSB Industries rises 10.2% - LSB Industries is up 10.2%, or 85c to $9.20.

09:53 EDT Genenta Science SPA (ADR) trading resumes

09:48 EDT LSB Industries rises 11.5% - LSB Industries is up 11.5%, or 96c to $9.31.

09:48 EDT Universal Insurance rises 12.1% - Universal Insurance is up 12.1%, or $2.05 to $19.01.

09:47 EDT Sibanye Stillwater falls -8.3% - Sibanye Stillwater is down -8.3%, or -36c to $3.97.

09:41 EDT Knightscope reseller TS&L issues purchase orders for 37 new devices - Knightscope announced that Knightscope Authorized Partner Transportation Solutions & Lighting, Inc., - Safety and Security Division - National Safety Systems issued purchase orders for 37 Emergency Communication Devices to be installed at a Georgia medical center, a Florida university, and to restock inventory. In addition to TS&L's new customers, the KAP issued a purchase order for 3 more K1 Blue Light Towers to hold in inventory for anticipated future sales.

09:34 EDT ArcBest's U-Pack partners with Affirm to offer financing options - ArcBest (ARCB) announced that its household goods moving service U-Pack(R) has partnered with Affirm (AFRM) to offer financing options for long-distance moves. This collaboration allows customers who apply and qualify to book a move now and pay on a payment plan later. U-Pack joins Affirm's network of 292,000 retail partners.

09:30 EDT Aurora Mobile trading halted, volatility trading pause

09:13 EDT Femsa enters agreement with Traxion to divest certain logistics operations - Fomento Economico Mexicano (FMX) has reached a definitive agreement with Grupo Traxion (GRPOF) to divest certain of FEMSA's logistics operations doing business as Solistica. The transaction includes FEMSA's transportation management operations in Mexico, as well as its contract logistics operations in Mexico, Colombia and Brazil. The transaction does not include FEMSA's LTL operations in Brazil. Total consideration for this transaction will be of approximately $4,060 million Mexican pesos, on a cash-free, debt-free basis. This transaction represents an additional step in the continued execution of the FEMSA Forward plan that was communicated in February of 2023. The transaction is subject to regulatory approvals and other customary conditions and is expected to close in the following months.

09:10 EDT Stellantis partners with Stellantis through Mopar dealer portal - Stellantis and Segway-Ninebot, a company in the micromobility transportation solutions and robotic service industries, announced a strategic partnership with Mopar, the global service, parts and customer care brand for Stellantis vehicles. Through this partnership, select Segway products including its electric scooters and GoKart are now available to Mopar's authorized Chrysler, Dodge, Fiat, Jeep and Ram dealers in North America. Mopar dealers will now have access to many of Segway's micromobility products. The full list of offerings includes: Segway's C2 Pro, E2 Pro, F2, Max G2 and GoKart Pro2.

09:09 EDT Silynxcom receives order from U.S. Air Force for headsets - Silynxcom has received a new order from the United States Air Force for its tactical communication products.

09:08 EDT Methes Energies announces b2 biOil available in returnable/reusable packaging - Methes Energies confirmed that their b2 biOil biodegradable/bio-based passenger car motor oils now made with both renewable and twice refined based stocks, will be packaged in; and, available shortly to direct to consumer and retail shoppers in returnable/reusable 32oz pouch available weights 0W-20, 5W-20 and 5W-30 shipping in both 5 pack and 6 pack quart quantities. Approximately 37.5 million gallons of petroleum oil is dumped into USA landfills each year from the more than 3 billion "used" motor oil bottles thrown-away with oil residue still left inside. In addition, packaging is an incremental cost that does not necessarily have to be passed on to the consumer or end user. These new preprinted ergonomically shaped fabricated pouches with single web to minimize seal areas uses up to 80% less total carbon footprint vs glass and/or plastic, ships in flat, ships out filled; and then, returned empty to us free of charge via envelope included in shipment for re-use/re-packaging or our proper disposal.

09:07 EDT Pineapple Energy's SUNation secures collaboration with Empire Automotive - SUNation Energy, the New York-based subsidiary of Pineapple Energy, has been chosen as the exclusive provider of electric vehicle home charging stations for Empire Automotive Group. Empire Automotive Group, one of the largest automotive dealership groups in New York State with a total of 20 locations, will provide complimentary SUNation Energy Level 2 EV charging stations to their new EV clients. The program will be rolled out to individual EAG dealers in the coming months.

09:06 EDT Cronos Group says Spinach is number one cannabis brand in Canada - Cronos Group announced that its brand Spinach has risen to the best-selling cannabis brand in the Canadian market.1 Spinach's market share outperformance represents Cronos' relentless commitment to quality, innovation, and bringing differentiated products to the competitive Canadian adult-use market. Since launching in November 2018, Spinach has quickly become the preferred choice among new and seasoned adult consumers alike. The success of Spinach is bolstered by its best-selling and breakthrough portfolio of products, including ranking first in both edibles and flower. "Our strategy has always been to develop a best-in-class portfolio of disruptive branded products that we can launch in new markets as cannabis regulations open globally," said Mike Gorenstein, Chairman, President and CEO, Cronos. "Spinach becoming the best-selling brand in Canada is validation of the portfolio we have in market but also our innovation and marketing capabilities. We're just getting started bringing new disruptive products to market in Canada and expanding our proven portfolio of borderless products to the global market."

09:05 EDT Definitive Healthcare launches Market Forecast solution - Definitive Healthcare announced the launch of Market Forecast, a powerful predictive analytics solution designed to help healthcare organizations uncover high-growth markets and service line opportunities to strengthen investments and partnerships. Delivering year-over-year growth rate and market demand projections up to 10 years out, Market Forecast enables business development teams, service line leaders, and strategy executives to see ahead to drive improved patient acquisition and retention, market expansion, and better resource allocation.

09:04 EDT Castor Maritime announces delivery of M/V Magic Ariel - Castor Maritime announces that on October 9, 2024, it took delivery of the M/V Magic Ariel, the 2020-built Kamsarmax bulk carrier vessel it had agreed to acquire as previously announced on September 30, 2024. The vessel acquisition was financed in its entirety with cash on hand. The M/V Magic Ariel will be employed under a time charter contract with a minimum duration of about seven months at a gross daily rate equal to 108% of the Baltic Panamax Index 5TC.

09:03 EDT Nokia, RACSA deploy first 5G network in Costa Rica - Nokia and Radiografica Costarricense, RACSA, announced that they have deployed the first 5G standalone network in Costa Rica. The project brings high-speed, low-latency 5G connectivity to key urban centers including San Jose, Cartago, and Limon, as well as rural communities across the country, marking a significant milestone in Costa Rica's digital evolution. The initial rollout phase saw the installation of 30 sites in major cities with a further 170 due later this year, with plans to expand to 500 sites in subsequent phases.

09:02 EDT Solventum appoints Ryan Egeland as Chief Medical Officer - Solventum has named Ryan Egeland Chief Medical Officer. Egeland joins Solventum from Crossfire Medical, where he has been CEO since 2022. Previously, he served as the Head of Strategic Ventures and Chief Medical Officer for Cardiovascular Systems. Prior to his tenure at CSI, Egeland led teams in Business Development & Licensing, Medical & Scientific Affairs, and Product Marketing at Medtronic, Covidien, and ev3.

08:53 EDT Starboard Value issues letter to Pfizer board of directors - Starboard Value, a significant shareholder of Pfizer, issued the below letter to company's board. "As you know, Starboard Value LP is a large investor in Pfizer Inc. As a significant shareholder, we care deeply about the Company and are committed to working constructively with management and the Board of Directors in order to create value for the benefit of all shareholders. As you are aware, we are scheduled to meet with Dr. Bourla, Mr. Narayen, and possibly other members of the Board on October 16, 2024, to present our views and discuss the best path forward for Pfizer. As has been reported in recent press articles, Starboard approached the Company's former Chief Executive Officer Ian Read and former Chief Financial Officer Frank D'Amelio during our diligence process. During these meetings both Mr. Read and Mr. D'Amelio expressed concerns about the trajectory of the business. As former Company executives and significant individual shareholders with a deep appreciation for Pfizer's customers, employees, and shareholders, Mr. Read and Mr. D'Amelio shared our desire to see Pfizer pursue a better path forward. Therefore, they offered to be of assistance. Let us be abundantly clear, this is the extent of our engagement with Mr. Read and Mr. D'Amelio and is entirely consistent with the public reporting to date. Unfortunately, recent events have been brought to our attention. Given the gravity of these events, and our optimistic belief that the Board may not have been consulted, we believe it important to share them in writing with the Board. Specifically, we understand that people within Pfizer and/or their representatives have contacted Mr. Read and Mr. D'Amelio and purportedly threatened to commence costly litigation against them, claw back prior compensation, and cancel unvested performance stock units, unless they publicly release a statement supporting the current Chief Executive Officer, Dr. Albert Bourla. While we cannot be certain that the Board did not authorize this behavior, we sincerely hope that all, or at least some, members of the Board were wholly unaware of this coercive conduct, which in our view constitutes a clear breach of fiduciary duty. Therefore, we ask the Board, as representatives of all shareholders, to immediately establish a special committee of Board members with clean hands to investigate the extent of this behavior, determine who approved and executed such conduct, and promptly hold the responsible parties accountable. To be clear, we believe this behavior is highly inappropriate, flagrantly unethical, and a significant breach of fiduciary obligations. While we are deeply troubled by this unfortunate series of events, we do hope to have a constructive engagement with the Company and look forward to meeting in-person this following Wednesday as scheduled."

08:39 EDT ConnectM acquires Green Energy Gains in all-stock transaction - ConnectM Technology has signed a definitive agreement to acquire Green Energy Gains. The Company's acquisition of Green Energy Gains is the second strategic acquisition since the Company's public listing, validating management's commitment to its operating plan. ConnectM has entered into a Purchase Agreement with the owners of Green Energy Gains, whereby the Company has acquired all of the issued and outstanding capital stock of GEG in an all-stock transaction. The transaction was completed on October 9, 2024. The Green Energy Gains operating model includes home energy assessments and modeling, and identification of weatherization opportunities for the home in order to reduce the homeowner's utility bills. ConnectM's core business model relies on an inorganic growth strategy. Green Energy Gains, as a strategic acquisition, strengthens ConnectM's portfolio and is expected to expand the customer base for its proprietary electric heat pump, offering a suitable solution for homeowners after no cost home energy assessments. The acquisition serves as an entry point for the HEA flywheel, providing whole home electrification solutions and unlocks the world of rebates and incentives for electrification. Green Energy Gains also brings a local partner ecosystem consisting of HVAC contractors which will serve as a distribution channel for ConnectM heat pumps and pave a path for potential future Master Service Agreements.

08:37 EDT Montana Technologies signs Abu Dhabi Sustainable Finance Declaration - Montana Technologies has signed the Abu Dhabi Sustainable Finance Declaration, further establishing the Company's commitment to sustainable development in line with the United Arab Emirates' Green Economy for Sustainable Development Initiative. The Abu Dhabi Sustainable Finance Declaration is a membership-based initiative that was established by Abu Dhabi Global Market in 2019 under the sponsorship of the UAE Ministry of Climate Change and Environment, the Central Bank of the UAE, and the Securities and Commodities Authority, with more than 135 members collaborating to foster and integrate sustainable investments within the UAE and the wider region. Additionally, Montana Technologies attended the Water, Energy, Technology, and Environment Exhibition on October 1 - 3, 2024 in Dubai. The Company's exhibition booth featured a prototype AirJoule unit that demonstrated its capability of producing pure distilled water from air during the conference.

08:37 EDT YY Group regains Nasdaq compliance with Minimum Bid Price Rule - YY Group Holding announces that the company has regained compliance with NASDAQ's Minimum Bid Price Rule, maintaining a consistent stock price above $1.00 for more than 12 consecutive business days. Chief Executive Officer and Executive Director, Mike Fu, expressed his gratitude, stating: "We are incredibly grateful for the support of our investors during this crucial time. Their confidence in YY Group's future has been a vital component of our ability to regain compliance with NASDAQ's standards. As we look ahead, our commitment to innovation, excellence, and shareholder value remains stronger than ever."

08:36 EDT Ormat Technologies secures land parcels in Nevada's BLM auction - Ormat Technologies has secured multiple land parcels in Nevada's Annual Bureau of Land Management Auction. These lease acquisitions will significantly support Ormat's ongoing exploration and expansion efforts in the state, further strengthening the company's commitment to advancing renewable energy solutions and meeting Nevada's increasing demand for sustainable energy. The newly leased parcels hold substantial potential for geothermal energy production including a new greenfield prospect, an expansion opportunity for an existing operational asset, and several additional parcels that will enhance Ormat's land position on an existing greenfield prospect.

08:35 EDT Trump Media announces release of Truth+ streaming app - Trump Media & Technology announced that it has successfully launched an app for Android mobile devices to access the Truth+ TV streaming platform. Now available in the Google Play Store, "Truth+ offers TV programming to Android users focusing on news, entertainment, faith-based content, weather, documentaries, children's content, and more, featuring both linear TV channels and Video on Demand," the company said.

08:34 EDT Edible Garden regains compliance with Nasdaq continued listing requirements - Edible Garden AG announced that it received notice from The Nasdaq Stock Market on October 9, 2024, indicating that Edible Garden had regained compliance with the minimum stockholders' equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1).

08:33 EDT SurgePays sgins Master Services Agreement with TerraCom - SurgePays has signed a Master Services Agreement with TerraCom, a wireless service provider and licensed Lifeline provider, effective October 3. SurgePays and TerraCom have agreed to finalize a stock purchase agreement to acquire the majority of TerraCom stock, subject to regulatory approval. SurgePays can now execute its stated strategy of offering Lifeline to its existing ACP subscriber base. The government reimbursement under the Lifeline program ranges from $9.25 to $34.25 per month, depending on the state. ACP customers can qualify almost identically under the Lifeline program.

08:33 EDT Palisade Bio received No Objection Letter from Health Canada for Phase 1 study - Palisade Bio announced that it has received a No Objection Letter from Health Canada for its Phase 1 human clinical study for PALI-2108 for the treatment of UC. The study is a Phase 1 Single Ascending Dose /Multiple Ascending Dose and food effects and includes multiple dose treatment of UC patients; Global UC market is expected to grow to nearly $10 Billion by 2028. "We are thrilled to receive a No Objection Letter from Health Canada in response to our Clinical Trial Application. This achievement marks the most important milestone to date for our PALI-2108 development program. We continue to believe in the potential of PALI-2108 to be the first approved PDE4 inhibitor for UC and more importantly, provide a much-needed effective and safe solution for UC patients still experiencing significant medical need. Our team remains focused on continuing preparations for the initiation of our Phase 1 clinical trial which is on track to commence before year end," commented J.D. Finley, Chief Executive Officer.

08:32 EDT Femasys to exhibit at ASRM 2024, participate in KEEPR Education Program - Femasys announces that the Company will be exhibiting at the American Society of Reproductive Medicine's 2024 Scientific Congress and Expo, being held October 19-23 in Denver, Colorado. The Company will be showcasing its solutions at booth #243. Femasys' FemaSeed and FemVue products will be featured in ASRM's Knowledge through Engagement and Education Program for Residents (KEEPR) program. The in-person resident program, being held October 23, will offer exclusive evidence-based and bias-free learning for residents. Through interactive workshops, skill-building activities, and advanced independent study, residents will explore important and trending topics with experts, including working with products that impact and preserve reproduction. Additionally, Femasys VP of Education and Global Training, Andrew Young was elected chairman of the ASRM Corporate Member Council, as voted by peers in reproductive medicine and corporate memberships. The Corporate Member Council is a partnership between ASRM officers, directors, and corporate members and is designed to facilitate open and ongoing dialogue between the two to drive education and innovation, which will serve to enhance the practice of reproductive medicine. Young will begin his one-year term at the close of the ASRM event. Femasys' CEO, Kathy Lee-Sepsick is also a member of the Council.

08:31 EDT T. Rowe Price reports preliminary AUM $1.63T as of September 30 - T. Rowe Price Group reported preliminary month-end assets under management of $1.63T as of September 30, 2024. Preliminary net outflows were $4.9B for September 2024 and $12.2B for the quarter-ended September 30, 2024. Preliminary quarterly net flows include $0.8B of Manager-driven distributions.

08:31 EDT Bridgeline Digital says fastener distributor selects AI-powered HawkSearch - Bridgeline Digital announces that a leader in fastener distribution has selected HawkSearch to enhance its search experience across 15 countries and 12 languages. The fastener distributor will leverage HawkSearch's Keyword & Concept Search features to improve product discovery. HawkSearch will enhance the leader's search accuracy, solve synonyms and abbreviation complexities, and improve the searchability of industry jargon. Additionally, it will optimize part number searches, ensure accurate results for terms with varying spacing, support different format variations, and incorporate advanced machine learning and reporting capabilities.

08:16 EDT WisdomTree reports September AUM $112.58B - WisdomTree released monthly metrics for September, including assets under management, or AUM, and flow data by asset class. WisdomTree achieved record AUM of nearly $113B. Inflows in U.S. equity products, cryptocurrencies, and bullish tactical positioning in oil and copper were offset by institutional reallocations out of cash positions, outflows in Japan Hedged Equity and profit taking in precious metals

08:12 EDT Maris-Tech is expanding its operations in the U.S. - Maris-Tech announced a major expansion into the U.S. market with the establishment of its new subsidiary, Maris North America. The move marks a significant milestone in Maris-Tech's ongoing global growth and reaffirms the Company's commitment to delivering cutting-edge solutions for the defense and homeland security sectors - both undergoing major growth in the U.S. Maris North America will serve as the strategic hub for Maris-Tech's operations across the U.S., further enhancing its ability to deliver localized support and forge new business relationships in North America.

08:12 EDT Brera Holdings' 'Brera F.C. Soccer Road to Glory' achieves over 4.4M views - Brera Holdings announced initial viewership results from the launch of the original skit series, Brera F.C. Soccer Road to Glory, in partnership with global content creator THADDBOII Productions. The Series features 24 episodes now available on X, Instagram, TikTok, and YouTube, and has amassed over 4,458,371 views since its launch on June 20, 2024. Brera F.C. Soccer Road to Glory follows a young underdog player striving for greatness in soccer while honoring his late father. Blending humor and heartfelt moments, it embodies the spirit of determination and community that Brera FC represents and highlights Brera's global expansion and social impact on the soccer community.

08:11 EDT Dayforce announces Dayforce Discover annual customer conference - Dayforce will host customers, partners, and industry visionaries for the new Dayforce Discover annual customer conference, to be held on November 11-14 at the Wynn Las Vegas. Registration is open for the in-person experience as well as the live stream of the conference's mainstage keynotes. Centered around the company's brand promise to make work life better, Dayforce Discover will bring together thousands of attendees around the world to ignite the power of the entire Dayforce community. In-person customers will be able to access more than 110 opportunities and experiences to learn, connect, and discover transformational value through the Dayforce platform.

08:10 EDT Clearmind announces IRB approval for FDA first-in-human trial of CMND-100 - Clearmind Medicine announced it has received Institutional Review Board, IRB, approval from one of its clinical sites in the U.S. for part A of its Phase I/IIa clinical trial in the United States for treating patients suffering from alcohol use disorder, AUD. The multinational, multi-center trial will assess the safety, tolerability, and pharmacokinetics of Clearmind's MEAI-based treatment, CMND-100. In addition to Johns Hopkins University, Maryland, USA, the trial will also take place at Yale School of Medicine, Connecticut, USA and IMCA Center in Ramat Gan, Israel. The Company has already secured FDA approval for its Investigational New Drug application to conduct the trial in the U.S., as well as approval from the Israeli Ministry of Health. IMCA's IRB approval has also been granted.

08:08 EDT Lipocine's brexanolone shows positive quantitative EEG results - Lipocine announced positive data from its qEEG study of its oral brexanolone, a proprietary bioidentical NAS being developed for the treatment of post-partum depression - PPD -. Results indicate robust central nervous system activity of oral brexanolone, with concentration- and time-dependent post-dose changes in qEEG. These results confirm GABAA positive allosteric modulation and support future development of oral brexanolone in neuropsychiatric indications. Following a single clinically relevant dose of oral brexanolone, subjects showed mean changes in all oscillatory spectral power bands. There was considerable beta band amplitude increase, including significant increase in beta2 amplitude across all cortical brain areas. Most of the treatment-related EEG changes were rapid occurring as early as 2 hours, with maximum and significant mean contrast values at 4 hours post dose with appreciable effects lasting 12 hours post-dose. Observed qEEG changes following oral brexanolone administration are consistent with therapies effective in managing depression, anxiety, tremor, and seizures. Oral brexanolone was well-tolerated in this Phase 1 study.

08:08 EDT SAIHEAT signs two MoUs concerning HEATNUC products - SAIHEAT announces the signing of two Memorandum of Understanding, MoUs, concerning HEATNUC products. These MoUs aim to promote cooperation in the Middle Eastern and international small modular reactor sectors while also gaining broader corporate management experience. The MoUs are intended to enhance SAIHEAT's competitiveness in the Middle Eastern and global markets, further advancing its regional localization strategy as they jointly expand cooperative markets. The MoU entered into with Kinze Nuclear Innovation International Energy Technology Services Co., Ltd., signifies the establishment of a strategic partnership focused on providing nuclear technology consulting and training, system, software, and hardware V&V, as well as digitalization services for the nuclear and oil & gas industries in China. The other MoU, inked with Jiangsu Jintonglingguang Nuclear Energy Technology Co., Ltd., outlines plan for joint production of nuclear equipment, SMR equipment and spare parts, aiming to enhance competitiveness and localization rates.

08:07 EDT RingCentral receives PAN-India license from DoT in India - RingCentral announced it has received the PAN-India license from the Department of Telecommunications, or DoT, to operate across all 22 telecommunications circles in India. As the first cloud provider to deliver fully-compliant Unified Communications as a Service and Contact Center as a Service solutions for India, RingCentral enables multinational organizations to connect their global offices with India branch offices for communication and collaboration across messaging, video, and phone with Global RingEX Select.

08:07 EDT HCM II Acquisition announces separate trading of Class A shares, warrants - HCM II Acquisition announced that, commencing October 10, 2024, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols "HOND" and "HONDW," respectively. Those units not separated will continue to trade on the Nasdaq under the symbol "HONDU."

08:06 EDT Armlogi Holding reports enhanced integration with Temu platform - Armlogi Holding announced advancements in its collaboration with Temu, the e-commerce platform. These developments are highlighted by a major upgrade of Armlogi's application programming interface to version 3.5 and full integration with its Warehouse Management System, enabling seamless service accessibility for all Temu customers. This enhanced integration allows Temu customers to fully leverage Armlogi'slogistics services, contributing to an uptake in user engagement. Currently, over 155 Temu customers utilize Armlogi's services on a daily basis, with the number expanding rapidly as the Company processes hundreds of new service requests each day. Armlogi is now handling and shipping over 3,000 Temu orders daily, which the Company believes underscores the scalability and efficiency of its logistics operations.

08:05 EDT Tilt Holdings' Commonwealth Alternative Care announces Fall engagement - TILT Holdings' Commonwealth Alternative Care announced that CAC is involved in several Fall events and seasonal community engagement activities. "Engaging with our patients and consumers on a daily basis is so important to us at CAC," stated Jordan Schulze, Director of Retail Operations. "Autumn is a natural time to give thanks, join together as a community, and celebrate the harvest season. Harvests play a monumental role in what we produce and offer at our dispensaries so meeting the customer and the community where they are and offering fun events is our way of connecting, giving back, and celebrating the fall season." CAC and its employees will be participating in a number of events throughout October and November to give back to its community, raise awareness of products available in the Taunton and Brockton locations, and celebrate the upcoming holidays in a festive way.

08:05 EDT RTX's Raytheon awarded $736M contract from U.S. Navy - Raytheon, an RTX business, was awarded a $736M contract from the U.S. Navy to produce AIM-9X SIDEWINDER missiles. This contract is for the improved Block II variant, which addresses hardware obsolescence through upgrades to ensure superior performance and long-term reliability. Work under this contract will take place in various locations within the continental U.S. through 2029.

08:04 EDT iBio, AstralBio provide update on myostatin program for obesity - iBio provided an update on the myostatin program for cardiometabolic disease and obesity in collaboration with AstralBio. iBio's technology stack enabled the Company to rapidly advance the joint myostatin program from inception to in vitro proof-of-concept in human muscle cells. Following early discovery, the companies have identified a molecule with therapeutic potential for treating muscle wasting and obesity, which is designed for subcutaneous administration and has potential for an extended half-life. The companies are currently working on plans to advance this molecule into non-cGMP in vivo studies in rodents and non-human primates with potential early readouts of the NHP in early 2025.

08:04 EDT Microchip announces VelocityDRIVE software platform, ethernet switches - To provide OEMs with comprehensive Ethernet solutions, Microchip Technology announces its new family of LAN969x Multi-Gigabit Ethernet Switches and VelocityDRIVE Software Platform, which is a turnkey Ethernet switch software solution and Configuration Tool based on standardized YANG models. The combination of LAN969x devices and VelocityDRIVE SP, the industry's first integration of CORECONF YANG, offers an innovative industry-standard network configuration solution. The CORECONF YANG standard aims to empower designers by separating software development from the hardware network layer. This reduces complexity and costs and accelerates the time to market.

08:03 EDT Achieve Life Sciences announces completion of enrollment in ORCA-OL trial - Achieve Life Sciences announced an update on the ORCA-OL clinical trial, evaluating long-term exposure of the novel 3 mg cytisinicline treatment dosing regimen in individuals who smoke cigarettes or vape nicotine. Enrollment for the ORCA-OL trial has been completed with an enrollment of 479 participants at 29 clinical trial sites across the United States. All clinical sites and participants were previously involved in Achieve's ORCA "Ongoing Research of Cytisinicline for Addiction" program for smoking and e-cigarette cessation studies, which is thought to have facilitated the rapid enrollment of this trial in just over four months

07:54 EDT PAVmed subsidiary Veris Health awarded $1.8M NIH grant for cancer care - PAVmed and its majority-owned digital health subsidiary Veris Health announced that Veris has been awarded a $1.8M grant from the National Institute on Minority Health and Health Disparities - NIMHD -, an institute of the National Institutes of Health - NIH -. The two-year grant will fund research to optimize and validate the Veris Cancer Care Platform for the needs of medically underserved cancer patients, in partnership with an academic cancer center. The research project will focus on patients facing language barriers, limited access to technology, and socioeconomic disparities.

07:48 EDT A2Z Smart Technologies signs framework agreement with Trixo - A2Z announced it has signed a framework agreement with Trixo for in-field installation, deployment, in-store and laboratory support, maintenance, help desk services and warranty fulfillment related to the company's Cust2Mate smart cart solutions to be rolled out in Mexico and Central America.

07:47 EDT Vireo Growth CEO Josh Rosen resigns, Amber Shimpa to succeed - Vireo Growth announced several leadership updates. Amber Shimpa, who has been with the Company since 2014 in various leadership roles of increasing responsibility, has been promoted to the role of CEO, effective immediately. Josh Rosen has resigned from the Company's Board of Directors and as the Company's CEO and interim CFO, effective immediately, to focus on his other business ventures. Mr. Rosen was first elected to the Board in August 2021, and appointed to executive leadership roles in November 2022, including, most recently, the roles of CEO and interim CFO. The Company has engaged Mr. Rosen going forward with a consulting agreement. Joe Duxbury has been appointed as Interim CFO while the Company searches for a permanent replacement. Mr. Duxbury has been with the Company since 2019 in financial and accounting roles of increasing responsibility, and most recently was serving as Vice President of Finance leading external reporting and investor relations.

07:42 EDT Signal Gold, NexGold enter definitive arrangement agreement for merger - NexGold Mining and Signal Gold announced that they have entered into a definitive arrangement agreement dated October 9, 2024 to combine the two companies and create a top near-term gold developer advancing NexGold's Goliath Gold Complex Project in Northern Ontario and Signal's Goldboro Gold Project in the historic Goldboro Gold District in Nova Scotia. Transaction Highlights: Two Canadian, near-term development projects, with Environmental Assessment Approvals in place, and a plan to attain production of over 200,000 ounces per year. Combined 4.7 million gold ounces of Measured and Indicated Mineral Resources and 1.3 million gold ounces of Inferred Mineral Resources between both companies. Significant growth potential at both Projects, across a combined property package of more than 60,000 hectares with potential along strike, at depth, and through new discoveries, including recent high-grade drill results at the western extension of the Goldboro Deposit. Concurrent non-brokered private placement financing for up to $11.5 million with NexGold Board and Management to subscribe for up to $1.0 million in the financing. In addition, current greater than 10% NexGold shareholder, Frank Giustra, will be participating in a meaningful way. Elimination of single asset risk for both Signal and NexGold, as both Projects are in advanced stages of permitting, with the completion of project permits expected in 2025. The Goliath Project has Federal Environmental Assessment Approval and the Goldboro Project has Provincial Environmental Assessment Approval. Combined team brings complementary skills and experience required for successful development, including geology, engineering, finance and capital markets, governance and sustainability. Robust Financial Position - The concurrent financing, proposed debt restructuring, and available cash resources provide significant funding to advance both projects towards a construction decision while deleveraging the combined entity. Value Creation - Operational and administrative synergies and savings with workflow sequencing and phased development approach for the two projects have the potential to unlock significantly more value for NexGold and Signal shareholders than could be realized on a standalone basis. Growth and consolidation strategy - The combined company will focus on showing growth in the Goldboro and Goliath Districts through drilling while assessing further opportunities for corporate growth. Restructured Credit Facility with Nebari to deleverage combined entity: It is proposed that Signal's outstanding credit facility of approximately US$20.4 million with Nebari and NexGold's US$6.0 million facility with Extract Capital will be repaid. NexGold is working to arrange a new US$12 million secured credit facility with Nebari over a term of 30 months and the issuance of US$4.0 million of NexGold shares, with a one year right to place. The arrangement would also grant a 0.6% NSR on the Goldboro Project to Nebari for US$6 million with a 100% buy-back right at the Company's option for the first 30 months. The combined company's board of directors will be led by Jim Gowans as Chair and will comprise six board members nominated by NexGold and two board members nominated by Signal. Reporting to the board of directors, the combined company will be managed by Kevin Bullock as President and Chief Executive Officer & Director, Jeremy Wyeth as Chief Operating Officer, and Orin Baranowsky as Chief Financial Officer. Pursuant to the Transaction, NexGold will acquire all the issued and outstanding common shares of Signal in exchange for common shares of NexGold by way of a plan of arrangement under the Business Corporations Act. Each SGNL share will be exchanged for 0.1244 of a NEXG Share Upon completion of the Transaction, existing NexGold and Signal shareholders will own approximately 71% and 29% of NexGold, respectively, on a fully diluted in-the-money basis. The Agreement contains customary reciprocal deal-protection provisions including non-solicitation covenants and a right to match any superior proposal as defined in the Agreement. Under certain circumstances, NexGold or Signal would be entitled to a reciprocal termination fee of C$1,750,000. Complete details of the Transaction will be included in a management information circular to be delivered to Signal shareholders in due course. It is anticipated that the Signal shareholder meeting and closing of the Transaction will take place in December 2024.

07:36 EDT ZenaTech's ZenaDrone launches IQ Nano Drone - ZenaTech announced that its subsidiary, ZenaDrone, is launching its IQ Nano product, part of the IQ series of indoor/outdoor drones. The IQ Nano is designed for customers in sectors such as warehousing and logistics to save costs and improve productivity while performing indoor inspection, monitoring and tracking processes including inventory management. The ZenaDrone IQ Nano is a 10x10-inch drone designed to perform regular and frequent inspections for applications such as bar code or RFID scanning, facility maintenance inspections, security monitoring, and 3D mapping specific to the needs of companies with warehouse, distribution, plants and industrial facilities. It is designed for autonomous use featuring integrated sensors, high-quality cameras and data collection. Weighing 1.5kg and with a flight time of up to 20 minutes before utilizing the automatic battery charging station, it is designed for hovering stability and for safety with obstacle avoidance capabilities.

07:33 EDT Intellia Therapeutics announces new date for investor webcast - Intellia Therapeutics announced a new date for its upcoming investor webcast to review the data from the Phase 2 study of NTLA-2002. The webcast will now be held on Thursday, October 24 at 8:30 a.m. ET. The Company had previously announced the investor webcast would be held on on Monday, October 28, 2024. There are no changes to the planned oral presentation at the 2024 American College of Allergy, Asthma & Immunology Annual Scientific Meeting, taking place October 24 - 28 in Boston, Massachusetts.

07:13 EDT Interactive Strength says Chuze Fitness orders multiple CLMBRs - Interactive Strength announced that Chuze Fitness has ordered multiple CLMBRs to install in four pilot locations out of the brand's 60 total locations.

07:11 EDT A2Z Smart Technologies signs framework agreement with Trixo - A2Z Cust2mate Solutions has signed a framework agreement with Trixo for in-field installation, deployment, in-store and laboratory support, maintenance, help desk services and warranty fulfillment related to the company's Cust2Mate smart cart solutions to be rolled out in Mexico and Central America.

07:10 EDT Zapp EV entered into turnkey EPC agreement with AIH Group - Zapp Electric Vehicles announced it has entered into a turnkey engineering, procurement and construction, EPC, agreement with AIH Group to deliver its low-cost manufacturing reference site in the Bangkok Free Trade Zone, which is a 100 acre campus near Thailand's capital city offering a total of 220,000 square meters in manufacturing capacity. The new reference site will showcase Zapp's flexible manufacturing and Gen-2 sustainable assembly innovations, and completion is expected by early 2025. It will also serve as a template for Zapp to roll out an anticipated series of such proprietary sites around the world that can be operated by any number of contract manufacturers, each with an annualized production capacity of up to 20,000 units and located in regions where Zapp sees significant sales growth potential.

07:08 EDT YXT.com expands customer base to include over 200 Fortune 500 companies - YXT.com Group has expanded its customer base to include over 200 Fortune 500 companies in China, further cementing its position as a go-to platform for enterprise learning and development. Among the notable partnerships are collaborations with industry leaders such as Hyundai Motor China, Shiseido China, BOE Technology, SANY Group, and Hailiang Group. The adoption of YXT.com's platform by these industry leaders underscores the company's competitive edge in providing cutting-edge, AI-powered corporate learning solutions. Clients have consistently recognized YXT.com for its comprehensive "software + content + service" integrated solution, which has proven instrumental in enhancing talent development and driving business growth.

07:08 EDT Symbotic announces agreement to implement warehouse automation for Walmex - Symbotic (SYM) announced it has entered into commercial agreements with Walmart (WMT) de Mexico y Centroamerica, Walmex, to implement Symbotic's industry-leading warehouse automation systems in two of the retailer's locations near Mexico City. Under the agreements, Symbotic will deploy its end-to-end systems at two greenfield distribution centers, with the first site currently breaking ground in the Bajio region of Mexico. The Bajio site will be one of the largest in Walmex's distribution network in Mexico and marks the largest system Symbotic has deployed as a single-phase project.

07:05 EDT Boralex acquires Sallachy Wind Farm project from WKN - In line with its growth ambitions in the United Kingdom, Boralex is pleased to announce the acquisition of the yet-to-be-constructed Sallachy Wind Farm project from German wind developer WKN, a subsidiary of the PNE Group. Once built, the wind farm will consist of nine wind turbines with a blade tip height of up to 149.9 metres and a combined installed generating capacity of up to 50MW. The wind farm will be situated on the Sallachy Estate in Sutherland, in the Highlands of Scotland. Sallachy Wind Farm was granted planning permission by The Highland Council in April 2022. It has a secured grid connection from 2028 and is expected to operate for 30 years.

07:04 EDT Tempest Therapeutics extends limited duration of stockholder rights plan - Tempest Therapeutics announced that its Board of Directors has adopted an amendment to its existing limited duration stockholder rights plan to extend the duration of the Rights Plan until the Annual Meeting of Stockholders. The Board did not adopt the extension to the Rights Plan in response to a specific takeover threat. In addition, the Rights Plan does not prevent the Board from engaging with parties or accepting an acquisition proposal if the Board believes that it is in the best interests of Tempest and all of its stockholders.

07:02 EDT Foghorn Therapeutics announces first patient dosed with FHD-909 - Foghorn Therapeutics announced that the first patient has been dosed with FHD-909 in the Phase 1 trial for SMARCA4 mutated cancers, with non-small cell lung cancer, NSCLC, as the primary target patient population. FHD-909 is a first-in-class oral, highly potent compound that demonstrates high selectivity for SMARCA2 over SMARCA4, a closely related protein.

06:55 EDT Mallinckrodt announces INOmax Evolve DS delivery system rollout - Mallinckrodt announced the rollout of the FDA cleared INOmax Evolve DS delivery system for the delivery of INOmax gas, for inhalation. This nationwide rollout follows the successful introduction of the INOmax Evolve DS Pilot program.

06:52 EDT The Buckle reports September 2024 net sales down 2.5% year-over-year - The Buckle reported comparable store net sales, for stores open at least one year, for the 5-week period ended October 5, 2024 decreased 4.3% from comparable store net sales for the 5-week period ended October 7, 2023. Net sales for the 5-week fiscal month ended October 5, 2024 decreased 2.5% to $100.6M from net sales of $103.1M for the prior year 5-week fiscal month ended September 30, 2023. Comparable store net sales year-to-date for the 35-week period ended October 5, 2024 decreased 6.1% from comparable store net sales for the 35-week period ended October 7, 2023. Net sales for the 35-week fiscal period ended October 5, 2024 decreased 5.1% to $750.5M vs. $790.9M for the prior year 35-week fiscal period ended September 30, 2023.

06:38 EDT Immatics provides update on Phase 1b trial of ACTengine in melanoma - Immatics N.V. announced updated Phase 1b clinical data on ACTengine IMA203 TCR-T targeting PRAME in melanoma patients and provided an update on SUPRAME, the upcoming Phase 3 trial to evaluate IMA203 in metastatic melanoma patients. As of August 23, 28 heavily pretreated patients with metastatic melanoma were treated at the recommended Phase 2 dose with IMA203 during the Phase 1b dose expansion part of the clinical trial. IMA203 monotherapy has maintained a favorable tolerability profile with no treatment-related Grade 5 adverse events in the safety population. The full IMA203 monotherapy tolerability profile is also generally consistent with that observed in the Phase 1b melanoma subset. All patients in dose expansion were treated with an updated version of IMA203. The data demonstrates a significant positive shift in median PFS and median OS between melanoma patients treated during Phase 1a and patients treated in Phase 1b. In addition, approximately half of all patients in the Phase 1b trial have a deep response. IMA203 T cells rapidly engrafted in all patients after a single dose and show a persistence of more than two years. Three associations/correlations were observed demonstrating high consistency of dose exposure, biological data and clinical outcome in all patients treated with IMA203 for which samples were available. On September 24, Immatics completed a Type D meeting with the FDA to confirm RP2D and the CMC package as well as discuss the trial design for the planned registration-enabling Phase 3 randomized-controlled clinical trial for IMA203. Written post-meeting minutes from the FDA have been received. The primary endpoint for full approval will be median PFS. A pre-specified interim analysis is planned for early 2026. The SUPRAME Phase 3 trial is planned to run globally with sites in the U.S. and Europe with the initial goal of seeking BLA approval in the U.S. The Phase 3 trial is on track to commence in December 2024. The company aims to submit a BLA in early 2027 for full approval.

06:31 EDT Babcock & Wilcox to sell its Italian and Swedish businesses for $40M - Babcock & Wilcox has reached an agreement to sell its Italy-based SPIG S.p.A. group of companies and Sweden-based Babcock & Wilcox Volund AB formerly known as Gotaverken Miljo AB to funds managed by AUCTUS Capital Partners AG, a European private equity firm, for approximately $40M, subject to customary adjustments and expenses. The deal is expected to close at the end of October and is subject to the satisfaction of customary closing conditions.

06:23 EDT Domino's Pizza sees FY25 annual global retail sales growth in line with FY24 - The company said, "The Company expects annual global retail sales growth and annual income from operations growth to be generally in line with its 2024 expectations."

06:21 EDT Roche obtains CE certification for companion diagnostic for VLOY - Roche announced that the VENTANA CLDN18 (43-14A) RxDx Assay is the first immunohistochemistry, IHC, companion diagnostic test to receive CE Mark approval for determining CLDN18 protein expression in tumours of patients with gastric or gastroesophageal junction, GEJ, adenocarcinoma. These patients now may be eligible for treatment with Astellas' targeted therapy VYLOY. Current guidelines for gastric/GEJ cancer recommend using biomarkers to guide therapeutic decision making. The new VENTANA CLDN18 (43-14A) RxDx Assay can help determine CLDN18.2 status and inform clinicians about the likelihood of patients benefiting from CLDN18.2 targeted therapy.

06:09 EDT CleanSpark achieves 30 exahashes per second in operational hashrate - CleanSpark announced it has achieved 30 exahashes per second, or EH/s, in operational hashrate. The company's hashrate has surged 200% since October 2023 through organic growth paired with acquisitions and the execution of a fleet upgrade, improving efficiency during the same period by nearly 20% and boosting the number of operational machines by 112%. The efficiency improvement strategy has resulted in increased computing power while consuming less energy and allowing for more hashrate to be generated with fewer machines. The company expects to surpass 37 EH/s before the end of 2024 and intends to continue its growth to 50 EH/s and beyond in 2025. Additional hashrate is anticipated to come online due to the expected acquisition closing of GRIID Infrastructure Inc this month. CleanSpark is one of the largest owned-and-operated publicly traded bitcoin miners in North America and has a portfolio of sites located in Georgia, Mississippi, Wyoming and Tennessee.

06:05 EDT Nokia Bell Labs, Vale enter research agreement - Nokia's (NOK) research arm, Nokia Bell Labs, and Vale (VALE) announced that they are signing a research agreement to implement a cognitive monitoring network service, enabling performance, reliability and safety enhancement of mining operations. The agreement builds on the already existing long-standing relationship at Vale's autonomous iron-ore mine in Carajas, Brazil. Carajas is the largest iron ore open pit mine in the world. The technology tested there offers a solution for creating networks that can sense, think and act ahead of time to enable mission-critical communication in a risky environment. Future mission-critical networks are expected to further enhance productivity and safety by including cognitive services in almost every layer. Nokia Bell Labs and Vale will collaborate to develop such systems within connectivity for enabling future mining operations and to automate planning intelligence. The relationship aims to create a holistic digital twin for mission-critical connected operations in the mine. The cognitive monitoring network service enables performance, reliability and safety enhancement of mining operations by utilizing data from mine production systems, including hauling trucks, and autonomous drillers, relating them with network KPIs.

05:58 EDT Unilever completes sale of Russian subsidiary to Arnest; terms not disclosed - Unilever has completed the sale of its Russian subsidiary to Arnest Group, a Russian manufacturer of perfume, cosmetics, and household products. The sale includes all of Unilever's business in Russia and its four factories in the country. The business in Belarus is also included in the sale. Unilever said: "Over the past year, we have been carefully preparing the Unilever Russia business for a potential sale. This work has been very complex, and has involved separating IT platforms and supply chains, as well as migrating brands to Cyrillic." The completion of the sale ends Unilever Russia's presence in the country. Terms of the deal are not being disclosed. Reference Link

05:49 EDT KKR-owned BMC to create two independent companies - KKR-owned BMC on Wednesday announced the decision to create two stand-alone, independent companies, BMC and BMC Helix. "BMC is an industry leader and key strategic partner to our customers in their AI-driven, multi-cloud journey," said Ayman Sayed, CEO and president of BMC. "As a result, our financial strength underpinned by our continued growth has allowed us to reach critical mass in size to where we can accelerate growth for each business and create even greater customer value with two market-leading companies. BMC and BMC Helix will be better equipped to deliver solutions quickly, keeping up with the evolving needs of our customers and reinforcing our industry leadership."BMC will remain the name of the company that includes the Intelligent Z Optimization and Transformation and Digital Business Automation business units, unifying hybrid IT with the most innovative portfolio of AI-driven infrastructure software, partners, and expertise. BMC Helix, the company encompassing the Digital Service and Operations Management business, will be focused on accelerating innovation, customer success, and the application of AI across the digital service and operations management business to capture more market share and lead the industry. The transition is expected to begin in early 2025, when BMC and BMC Helix will officially begin operating as two independent organizations.

05:24 EDT BW LPG provides update on Q3 Product Services performance - BW LPG provided an update on its Product Services' Q3 segment performance. In Q3, BW Product Services reported an estimated gross profit of approximately $71M. This gross profit was mainly a result of $86M of unrealized marked to market value of open cargo contracts and hedging transactions, realized trading gains of $16M, offset by hedging loss of $31M on the realized positions. The open cargo value is reflected in the overall trading book value and will be gradually revalued and realized in the next 12 months, as per standard methodology. After general and administrative expenses and income taxes, BW Product Services reported an estimated net profit of approximately $60M for the quarter. The average value-at-risk, or VAR, for the quarter was approximately $5M. BW LPG will release its Q3 financial report on December 2.